What Caught Our Attention in the Investment World? – Week of April 11-14, 2022

By Kuldip K. Ambastha Peloton Interactive, Inc. (PTON), a luxury exercise gear maker, had its stock drop by -4.6% for the trading day of Thursday, April 14, 2022. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of May 3-7, 2021; By Kuldip K. Ambastha” and “What Caught Our …

What Caught Our Attention in the Investment World? – Week of July 12-16, 2021

By Kuldip K. Ambastha On Friday, July 16, 2021, the stock of Moderna, Inc. (MRNA) was up by +10.3% for the trading day. Moderna, a biotechnology company, has been highly successful in its efforts to develop a coronavirus (COVID-19) vaccine. Late on Thursday, July 15, 2021, S&P Dow Jones Indices announced that Moderna will become …

What Caught Our Attention in the Investment World? – Week of May 3-7, 2021

By Kuldip K. Ambastha Peloton Interactive, Inc. (PTON) is a luxury exercise gear maker which was in the news prominently during this past trading week. The company was also mentioned on this website once before (What Caught Our Attention in the Investment World? – Week of December 23-27, 2019). On Wednesday, May 5, 2021, the …

What Caught Our Attention in the Investment World? – Week of February 24-28, 2020

By Kuldip K. Ambastha and Anil K. Ambastha On Tuesday, February 25, 2020, the stock of Moderna, Inc. (MRNA) rose by 27.8% for the day. As the coronavirus (COVID-19) has spread around the world and led to a sell-off in the capital markets, Moderna, Inc. announced that its coronavirus vaccine candidate is scheduled to be …

What Caught Our Attention in the Investment World? – Week of December 23-27, 2019

By Kuldip K. Ambastha and Anil K. Ambastha HAPPY HOLIDAYS, EVERYBODY! During this week of Christmas, Peloton Interactive, Inc. (PTON) and WW International, Inc. (formerly Weight Watchers International, Inc.) (WW) caught our eye. On Thursday, December 26, 2019 (the day after Christmas 2019), Peloton dropped by 6.1%, while WW International fell by 8.5%. Peloton is …

What Caught Our Attention in the Investment World? – Week of September 9-13, 2019

By Kuldip K. Ambastha and Anil K. Ambastha Acadia Pharmaceuticals Inc. (ACAD) is a biopharmaceutical company which has Nuplazid (aka: pimavanserin) in its product pipeline. Nuplazid has been used by individuals suffering from Parkinson’s disease-linked psychosis. Acadia has now analyzed Nuplazid in relation to individuals suffering from dementia-related psychosis. Currently, no approved drugs exist in …